OXAZOLIDONE DERIVATIVES AS PR MODULATORS

COMMONS THOMAS JOSEPH, FENSOME ANDREW, HEFFERNAN GAVIN DAVID, MCCOMAS CASEY CAMERON, WOODWORTH RICHARD PAGE, WEBB MICHAEL BYRON, MARELLA MICHAEL ANTHONY, MELENSKI EDWARD GEORGE, BERNOTAS RONALD CHARLES
2011
OA: closed Metadata only
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-06 ⓘ

Oxazolidone compounds are disclosed for treating various hormone-related conditions including contraception, fibroids, endometriosis, and hormone-dependent carcinomas.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Disclosed herein are oxazolidone compounds of the given formula wherein the substituents are as defined within the specification. Said compounds are useful for treating hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome or hormone-dependent carcinomas, providing hormone replacement therapy, simulating food intake or synchronizing estrus.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-25T06:15:30.875455+00:00